Colon cancer population screening
In 2020, 1.8 million of the nearly 2.2 million people from the target group received an invitation. The participation rate in 2020 was 72% the same as in 2019. Of the participants who took a stool test, an average of 1.2% had colon cancer or an advanced polyp: 1.6% of the men and 0.9% of the women.
An abnormality was found in approximately 1/3 of the people who received a visual examination (in 2,319 people intestinal tumors and 13,999 people advanced polyps).
The number of abnormalities found decreases very gradually from 2014. This is because the average age of the participants is falling and there are fewer abnormalities among young participants. In addition, people have been called up more often since the start of the population screening, so many precursors of colorectal cancer will have been detected by the population screening earlier.
Breast Cancer Population Screening
In 2020, 55% of the target group received an invitation for the breast cancer population screening in 2020; in total that is more than 750,000 women. In 2019, that was still 97%, with 1.3 million invitations. In addition to the shutdown due to COVID-19, the shortage of staff in the screening also played a role in the delay in inviting.
In 2020, 70% of the invited women took part in the survey; in 2019 that was 76%. Since the shutdown, women have received an open invitation, instead of an invitation on a fixed date and time. In this way, the available research capacity is optimally used. The turnout rate may also be lower in 2020 due to fears of COVID-19, despite precautions taken in the screening units to keep their distance.
The population screening detected 6,362 cases of breast cancer in 2019.
Fewer people received invitations to cancer population screening in 2020
Source link Fewer people received invitations to cancer population screening in 2020